Therefore, a good understanding of the LGALS3’s regulatory mechanisms, its downstream effectors, and its role in tumor immune microenvironment is of great importance for alone or in combination treatment in HCC. This evidence concerns the gene LGALS3 and hepatocellular carcinoma.